Early research (Phase 1)Study completedNCT05172544What this trial is testingTrial of an Inactivated Yellow Fever Virus VaccineWho this might be right forYellow Fever Najit Technologies, Inc. 26
Post-approval studies (Phase 4)Study completedNCT03725618What this trial is testingImmunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months OldWho this might be right forYellow Fever Centers for Disease Control and Prevention 1,788
Large-scale testing (Phase 3)Study completedNCT03342898What this trial is testingImmunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in AdultsWho this might be right forDengue Takeda 900
Not applicableStudy completedNCT03870061What this trial is testingEvaluation of an Infant Immunization Encouragement Program in NigeriaWho this might be right forTuberculosisDiphtheriaTetanus+8 more GiveWell 5,187
Post-approval studies (Phase 4)Study completedNCT05374317What this trial is testingStudy of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever VaccineWho this might be right forYellow Fever Vaccination Reaction US Army Medical Research Institute of Infectious Diseases 88
Not applicableStudy completedNCT02572518What this trial is testingImmunity After Two Doses of Yellow Fever VaccineWho this might be right forYellow Fever The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 440
Early research (Phase 1)Ended earlyNCT03891420What this trial is testingEvaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19Who this might be right forCOVID-19Yellow Fever BioCryst Pharmaceuticals 24
Not applicableStudy completedNCT03458780What this trial is testingYellow Fever Immune Response at Single Cell ResolutionWho this might be right forHealthy Rockefeller University 6
Post-approval studies (Phase 4)Study completedNCT03368495What this trial is testingImmunogenicity of Co-administered Yellow Fever and Measles, Mumps, and Rubella (MMR) VaccinesWho this might be right forVaccine Response Impaired Alba Maria Ropero 851
Testing effectiveness (Phase 2)Study completedNCT01943305What this trial is testingThe Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in HumansWho this might be right forYellow FeverEncephalitis, Japanese Singapore General Hospital 84
Post-approval studies (Phase 4)Active Not RecruitingNCT04083430What this trial is testingCytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D VaccinationWho this might be right forHealthyCytotoxicityYellow Fever Vaccination Reaction University of Aarhus 60
Large-scale testing (Phase 3)Study completedNCT01466387What this trial is testingA Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsWho this might be right forMeningococcal DiseaseMeningococcal MeningitisTyphoid+3 more Novartis 552
Testing effectiveness (Phase 2)UnknownNCT05568953What this trial is testingAn Experimental Medicine Decipher of a Minimum Correlate of Cellular ImmunityWho this might be right forInfectious DiseaseYellow FeverJapanese Encephalitis+1 more Singapore General Hospital 70
Post-approval studies (Phase 4)Study completedNCT01847872What this trial is testingIPV Clinical Trial - The GambiaWho this might be right forPoliomyelitis London School of Hygiene and Tropical Medicine 1,504
Not applicableStudy completedNCT03541694What this trial is testingPassive Enhanced Safety Surveillance of Stamaril® Vaccine in KoreaWho this might be right forYellow Fever Sanofi Pasteur, a Sanofi Company 622
Large-scale testing (Phase 3)Study completedNCT07222059What this trial is testingPhase 3 Single Arm, Open Study on vYF in AdultsWho this might be right forYellow Fever Sanofi Pasteur, a Sanofi Company 254
Not applicableUnknownNCT04235361What this trial is testingMobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRCWho this might be right forEbola Virus DiseaseMalariaTyphoid Fever+3 more University of Stirling 500
Testing effectiveness (Phase 2)Study completedNCT00788151What this trial is testingStudy of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 YearsWho this might be right forDengue VirusDengue FeverDengue Hemorrhagic Fever+1 more Sanofi Pasteur, a Sanofi Company 300
Early research (Phase 1)Study completedNCT00995865What this trial is testingTrial of Yellow Fever Inactivated VaccineWho this might be right forYellow Fever GE Healthcare 60
Testing effectiveness (Phase 2)Study completedNCT04269265What this trial is testingThe Effect of Inflammation and Damage to Lymph Node Structures on Durable Protective Immunity Following Yellow Fever VaccinationWho this might be right forYellow Fever University of Minnesota 43